The high affinity folate receptor (FR) is overexpressed on approximately 80% of all cancer types and activated macrophages associated with numerous inflammatory conditions. Consequently, FR has emerged as an attractive target for the selective delivery of folate guided therapeutic agents and for development of diagnostic strategies that are able to identify folate receptor positive cancer and immune cells in both in vitro and in vivo assays. This report describes a rapid method for the construction of a folate fluorophore targeting ligand with a biotin functional group, for the facile and rapid conjugation of streptavidin species containing either imaging agents for multimodal imaging or therapeutic agents. This strategy should prove useful...
Folate receptor (FR) can be used as a therapeutic target because of its expression on different epit...
Folate receptor (FR) can be used as a therapeutic target because of its expression on different epit...
The use of high affinity ligands to target drugs specifically to tumor cells is receiving increased ...
Discovery and development of folic acid based receptor targeting started in late 1991 and early 1992...
Folate receptor-targeted imaging agents have previously been utilized to image and diagnose both can...
The folate receptor has achieved great importance for use in targeted drug delivery and in vitro and...
In this literature thesis, the folate-fluorescein-PEG-biotin (FFPB) complex and ligand have been suc...
Over expression of Folate receptors in a variety of tumors led to the discovery of folate receptor b...
Folic acid has been frequently exploited to target attached drugs to cells that overexpress a folate...
Folic acid can combine specifically with folate receptors (FRs) which are overexpressed on the epith...
Two approaches to design folic acid conjugates for specific intracellular uptake against folate rece...
In this thesis, folate conjugates with imaging agents are studied as tumor tissue diagnostics. The l...
In normal tissues, the expression of folate receptors is low and limited to cells that are important...
In recent years methods of selective targeting of pathologic cells have become increasingly importan...
The folate receptor (FR) is overexpressed on a variety of tumor types, whereas its distribution in n...
Folate receptor (FR) can be used as a therapeutic target because of its expression on different epit...
Folate receptor (FR) can be used as a therapeutic target because of its expression on different epit...
The use of high affinity ligands to target drugs specifically to tumor cells is receiving increased ...
Discovery and development of folic acid based receptor targeting started in late 1991 and early 1992...
Folate receptor-targeted imaging agents have previously been utilized to image and diagnose both can...
The folate receptor has achieved great importance for use in targeted drug delivery and in vitro and...
In this literature thesis, the folate-fluorescein-PEG-biotin (FFPB) complex and ligand have been suc...
Over expression of Folate receptors in a variety of tumors led to the discovery of folate receptor b...
Folic acid has been frequently exploited to target attached drugs to cells that overexpress a folate...
Folic acid can combine specifically with folate receptors (FRs) which are overexpressed on the epith...
Two approaches to design folic acid conjugates for specific intracellular uptake against folate rece...
In this thesis, folate conjugates with imaging agents are studied as tumor tissue diagnostics. The l...
In normal tissues, the expression of folate receptors is low and limited to cells that are important...
In recent years methods of selective targeting of pathologic cells have become increasingly importan...
The folate receptor (FR) is overexpressed on a variety of tumor types, whereas its distribution in n...
Folate receptor (FR) can be used as a therapeutic target because of its expression on different epit...
Folate receptor (FR) can be used as a therapeutic target because of its expression on different epit...
The use of high affinity ligands to target drugs specifically to tumor cells is receiving increased ...